Yahoo Finance

Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia

Ghent, Belgium – 31 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart ...
Yahoo Finance

Sequana shares surge after FDA approval for alfapump

The US Food and Drug Administration (FDA) has approved Sequana Medical's alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis. The agency's greenlight makes Sequana's ...
PharmaTimes

FDA approves Sequana Medical’s Alfapump for ascites treatment

Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...
Healio

Alfapump implant gains FDA premarket approval for recurrent, refractory cirrhotic ascites

Please provide your email address to receive an email when new articles are posted on . The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of ...
Business Wire

Sequana Medical signs collaboration agreement with Fresenius Medical Care for the marketing and distribution of the alfapump ® system.

ZURICH--(BUSINESS WIRE)--Sequana Medical, a Swiss-based medical device company, announced today that it has entered into an agreement with Fresenius Medical Care to commercialize its innovative ...
Yahoo

Sequana Medical’s alfapump for Liver Ascites Now at 5 U.S. Medical Centers

Sequana Medical said the company now has five medical centers using its alfapump, the first FDA-approved active implantable medical device to treat liver ascites due to cirrhosis. The new ...
BioWorld

Sequana reports positive second interim results from pivotal Alfapump study

Sequana Medical NV reported positive results from the second interim analysis of its POSEIDON pivotal study evaluating the Alfapump for the treatment of recurrent or refractory ascites due to liver ...
Pharmabiz

Sequana Medical completes alfapump implantations in POSEIDON, the North American pivotal alfapump study

Sequana Medical NV, an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites, and heart failure, announces that it has completed implanting patients in ...
BioWorld

Sequana gets FDA nod for Alfapump to treat patients with ascites

Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...
TheHealthSite

Alfapump - an implant that drains fluid build-up seen in cancer

A new implant that removes the dangerous build-up of fluid caused by many cancers in the body of patient could potentially transform cancer treatment. Cancer cells secrete a fluid called ascites ...
manilatimes

Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia

Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a significant risk of complications that are life threatening and require ...